Skip to main content
Premium Trial:

Request an Annual Quote

Volpara Solutions, Ambry Genetics Form Breast Cancer Management Alliance

NEW YORK — Volpara Health Technologies said on Wednesday that its Volpara Solutions subsidiary has signed an agreement to link its cancer screening and practice management platform with Ambry Genetics' program for identifying high-risk breast cancer patients.

Under the terms of the deal, Volpara's Aspen Breast software for medical practice management will include an online ordering process for Ambry's genetic tests. Meanwhile, Volpara's Density software for assessing volumetric breast density will be included in Ambry's Comprehensive, Assessment, Risk, and Education (CARE) program, which uses risk assessment models and genetic testing to identify high-risk women and guide future screening and treatment decisions.

Additional terms were not disclosed.

About a year ago, Wellington, New Zealand-based Volpara Health Solutions acquired Lynnwood, Washington-based Medical Reporting Systems, which developed Aspen Breast. Aliso Viejo, California-based Ambry is a unit of Japan's Konica Minolta.

The Scan

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.

Vitamin D From Tomatoes

According to Reuters, researchers in the UK have gene-edited tomatoes so their fruit contains vitamin D.

Cause Not Yet Spotted

NPR reports that a new study was unable to find a cause for persistent long COVID symptoms.

PNAS Papers on Central African Hunter-Gatherers, Myopia Development, Ancient Microtia Allele

In PNAS this week: population patterns among Central African hunter gatherers, effect of myopia-linked gene variant, and more.